THE USE OF OXIDATIVE STRESS BIOMARKERS IN PREDICTING ONCOGENIC TRANSFORMATION OF LEUKOPLAKIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. MAJMHS 2025, 1 (2), 86-93.